Clovis Oncology Inc
Change company Symbol lookup
Select an option...
CLVS Clovis Oncology Inc
WDC Western Digital Corp
VER VEREIT Inc
STOR STORE Capital Corp
BKCC BlackRock Capital Investment Corp
MANH Manhattan Associates Inc
RF Regions Financial Corp
QRVO Qorvo Inc
PRTY Party City Holdco Inc
PLAY Dave & Buster's Entertainment Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company’s product Rubraca (rucaparib), an oral small molecule inhibitor of poly adenosine diphosphate (ADP)-ribose polymerase (PARP), is marketed in the United States for two indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The Company also provides Lucitanib, which is an investigational, oral, potent inhibitor of the tyrosine kinase activity of vascular endothelial growth factor receptors one through three (VEGFR1-3), platelet-derived growth factor receptors alpha and beta, and fibroblast growth factor receptors one through three (FGFR1-3).

Closing Price
$6.92
Day's Change
-0.13 (-1.84%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.08
Day's Low
6.54
Volume
(Light)
Volume:
7,447,254

10-day average volume:
11,981,897
7,447,254
  • Prev Close
    7.05
  • Today's Open
    6.96
  • Day's Range
    6.54-7.08
  • Avg Vol (10-day)
    12.0M
  • Last (time)
    3:59p ET 05/29/20
  • Last (size)
    2.0K
  • 52-Wk Range
    2.93 - 17.37
    LowHigh
  • (10/28/19 - 12/02/19)
    136.18%
  • 138.2%
  • Market Cap
    608.9M
  • Shares Outstanding
    88.0M
  • -7.19
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.5
  • 36.90
  • (% of float 05/15/20)
    30.77

Latest News

May 28, 2020
8:00 am ET
BusinessWire
May 27, 2020
8:30 am ET
PR Newswire
May 21, 2020
4:10 pm ET
BusinessWire
May 18, 2020
8:05 pm ET
BusinessWire
4:02 pm ET
BusinessWire
May 15, 2020
2:30 pm ET
BusinessWire
May 14, 2020
9:18 am ET
Zacks
May 05, 2020
4:05 pm ET
BusinessWire
April 29, 2020
4:05 pm ET
BusinessWire
April 27, 2020
6:26 am ET
MarketWatch
6:26 am ET
MarketWatch
April 21, 2020
4:05 pm ET
BusinessWire
April 14, 2020
5:08 pm ET
BusinessWire
April 13, 2020
9:00 am ET
Globe Newswire
March 12, 2020
8:45 am ET
PR Newswire
March 03, 2020
8:30 am ET
BusinessWire
March 02, 2020
4:00 am ET
BusinessWire
February 06, 2020
11:17 am ET
MarketWatch
January 15, 2020
9:27 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.